Anomaly Bio
Type
startup
Founded
2025
Funding captured
$2.6m
Deals captured
1
About Anomaly Bio
Anomaly Bio is a Singapore-based biotech startup that develops next-generation bio-based inputs using advanced fermentation and strain engineering. The company engineers microbes to convert sugars into sustainable, scalable ingredients for applications across crop protection, nutrition, and personal care. It focuses on building laboratory and pilot-scale manufacturing capabilities, advancing metabolic engineering research, and delivering on-demand bio-ingredient production to reduce reliance on fragile global supply chains.
Anomaly Bio funding captured (1)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Pre-Seed | Nov 12, 2025 | $2.6m |